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Maternofetal pathogen transmission is partially controlled at the level of the maternal
uterine mucosa at the fetal implantation site (the decidua basalis), where maternal and
fetal cells are in close contact. Toll-like receptors (TLRs) may play an important role in
initiating rapid immune responses against pathogens in the decidua basalis, however
the tolerant microenvironment should be preserved in order to allow fetal development.
Here we investigated the expression and functionality of TLRs expressed by decidual
macrophages (dMs) and NK cells (dNKs), the major decidual immune cell populations.
We report for the first time that both human dMs and dNK cells express mRNAs encoding
TLRs 1-9, albeit with a higher expression level in dMs. TLR2, TLR3, and TLR4 protein
expression checked by flow cytometry was positive for both dMs and dNK cells. In vitro
treatment of primary dMs and dNK cells with specific TLR2, TLR3, TLR4, TLR7/8, and
TLR9 agonists enhanced their secretion of pro- and anti-inflammatory cytokines, as well
as cytokines and chemokines involved in immune cell crosstalk. Only dNK cells released
IFN-γ, whereas only dMs released IL-1β, IL-10, and IL-12. TLR9 activation of dMs resulted in
a distinct pattern of cytokine expression compared to the other TLRs. The cytokine profiles
expressed by dMs and dNK cells upon TLR activation are compatible with maintenance of
the fetotolerant immune environment during initiation of immune responses to pathogens
at the maternofetal interface.
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INTRODUCTION
The maternofetal interface is a unique anatomical site, in that it
maintains a state of local immune tolerance to the semiallogenic
fetus while simultaneously ensuring host defenses against micro-
bial pathogens. Intrauterine bacterial and viral infections are con-
sidered to be associated to pregnancy disorders (preterm labor,
fetal growth restriction, stillbirth) (Goldenberg and Thompson,
2003; Adams Waldorf and McAdams, 2013). Bacteria are able to
shuttle from the lower genital tract to the non-pregnant intrauter-
ine cavity (Egli and Newton, 1961) and are detected at the
maternofetal interface (DiGiulio et al., 2008; Han et al., 2009;
Castro-Leyva et al., 2012). Viruses are also present at the mater-
nofetal interface (Chouquet et al., 1997; Fidler et al., 2004; Picone
et al., 2013). Among them, herpes simplex virus, human immun-
odeficiency type 1 virus and human cytomegalovirus can infect
placental cells (Douglas et al., 1991; Norskov-Lauritsen et al.,
1992; Lagaye et al., 2001;Weisblum et al., 2011). However, in utero
transmission of these viruses is relatively rare and seems to be
controlled (Chouquet et al., 1997; Fidler et al., 2004; Picone et al.,
2013). To ensure host defenses against invading pathogens, the
maternofetal interface must efficiently recognize a broad range
of pathogen-associated molecular patterns (PAMPs) in order to
provide an immediate immune response.
The maternofetal interface is composed of the placenta (of
fetal origin) and the maternal uterine mucosa (decidua) (Moffett-
King, 2002). The decidua basalis is located at the implantation
site, in close contact with the placenta and the maternal blood.
Up to 40% of all decidua basalis cells are leukocytes. During the
first trimester of pregnancy, NK cells (dNKs) account for 70%
of decidual leukocytes, T cells for 10%, and CD14+ antigen-
presenting cells for 20% (Trundley and Moffett, 2004; Houser
et al., 2011; Svensson et al., 2011). CD14+ antigen-presenting
cells display amacrophage-like phenotype and are thus referred to
here as decidual macrophages (dM) (Trundley and Moffett, 2004;
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Houser et al., 2011; Svensson et al., 2011). Decidual immune
cells have to maintain a tolerant environment and thus play
a crucial role in embryo implantation and fetal development.
DMs promote fetal implantation by secreting soluble factors and
are also involved in tissue remodeling (Houser et al., 2011).
Decidual NK cells are involved in angiogenesis and spiral artery
remodeling, and regulate decidual invasion by placental tro-
phoblast cells (Hanna et al., 2006; Lash et al., 2006a,b). Besides
these crucial functions of inducing and maintaining a tolerant
microenvironment, dMs and dNK cells might also have the crit-
ical task of initiating a rapid immune response against invading
pathogens.
Toll-like receptors (TLRs) are innate immune receptors able
to sense a broad variety of PAMPs, thereby contributing to
frontline defenses against pathogens. Ten human TLR genes
(TLR1-10) have been identified, encoding receptors with a
leucine-rich repeat ectodomain that recognizes PAMPs (Guan
et al., 2010; Kawai and Akira, 2011). TLR1, TLR6, and TLR10
form heterodimers with TLR2. Microbial membrane patterns are
detected by cell-surface TLR1/2, TLR2, TLR4, TLR5, TLR2/6, and
TLR2/10, while pathogen nucleic acid sequences are recognized
by TLR3, TLR7, TLR8, and TLR9 located in intracellular vesicles
(Guan et al., 2010; Kawai and Akira, 2011). PAMP recognition by
TLRs induces the secretion of a large panel of cytokines, including
pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, and IL-8), type
I/II interferons (IFN-α, IFN-β, IFN-γ), and chemokines, which in
turn activate innate immune cells and direct adaptive immunity
(Hart et al., 2005; Kwissa et al., 2012).
All TLR mRNAs are known to be expressed and to be modu-
lated during the course of pregnancy (Canavan and Simhan, 2007;
Krikun et al., 2007) in human total decidual cells that include
maternal stromal and immune cells altogether with placental tro-
phoblast cells which invade the mucosa. Moreover TLR2, TLR3,
and TLR4 have been shown to be functional in total decidual tis-
sue in the first trimester and/or at term (Canavan and Simhan,
2007; Krikun et al., 2007) and primary trophoblast cells are
reported to have functional TLR2, TLR3, and TLR4 (Abrahams
et al., 2004; Patni et al., 2009). To our best knowledge, there is
so far no data about the expression and function of TLRs within
the different immune cell subsets of the human decidua, particu-
larly in dMs and dNK cells which are the more abundant innate
immune cells in this mucosa.
The aims of this study were to investigate TLR expression
in decidual macrophages and NK cells, and to characterize the
cytokine profile resulting from TLR activation of both cell types,
in order to understand the roles of these cells in antimicrobial
defenses within a tolerogenic environment.
MATERIALS AND METHODS
ETHICS STATEMENT
All the women donors in this study provided their writ-
ten informed consent. The study was approved by Assistance
Publique des Hôpitaux de Paris (n◦VAL/2011/06-41/02), Agence
de Biomédecine (n◦PFS08-013) and the biomedical research
committee of the Pasteur Institute, Paris, France (n◦RBM/
2005.024).
HUMAN DECIDUA BASALIS TISSUE COLLECTION
Decidua basalis tissue samples were obtained from healthy
women undergoing voluntary termination of pregnancy during
the first trimester (8, 9, 10, 11, 12 weeks of gestation) at Antoine
Béclère Hospital (Clamart, France) or Pitié-Salpêtrière Hospital
(Paris, France).
ISOLATION OF DECIDUAL MONONUCLEAR CELLS, CD14+ DECIDUAL
MACROPHAGES, AND DECIDUAL NK CELLS
Decidual mononuclear cells were isolated as previously described
(Marlin et al., 2012). Briefly, freshly isolated decidua basalis tissue
was digested under agitation in PBS (Gibco)- 1mg/ml collage-
nase IV (Sigma)- 50U/ml DNase (Roche) for 1 h. Cell suspension
was successively filtered through 100, 70, and 40μm nylon cell
strainer andmononuclear cells were isolated by a density gradient
step with Lymphocyte Separation Medium (PAA). DMs and dNK
cells were purified by flow sorting or by positive selection with
magnetic beads. Cell sorting of both dM and dNK cells was per-
formed on 2 decidua samples, decidual mononuclear cells were
stained with Amcyan-labeled anti-CD45, Pacific Blue-labeled
anti-CD14, Alexa700-labeled anti-CD56 (Becton Dickinson) and
PE-TexasRed-labeled anti-CD3 (Beckman Coulter) antibodies.
CD45+ CD14+ CD3− CD56− dMs and CD45+ CD14− CD3−
CD56bright dNK cells were sorted with a MoFlo ASTRIOS device
(Beckman Coulter). DM and dNK cells flow sorted purity
was >99%. DMs and dNK cells were also purified from decid-
ual mononuclear cells by using anti-CD14+ and anti-CD56+
magnetic beads, respectively, as recommended by the manufac-
turer (Miltenyi). DM and dNK cell purity was controlled by flow
cytometry with an LSRII 2-Blue 2-Violet 3-Red 5-Yelgr laser con-
figuration (BD Biosciences) and FlowJo 9.1.3. software (Tristar).
Magnetic bead purified dM and dNK cells purity was 90 ± 1.17
and 89.8 ± 2.38 respectively (mean ± s.e.m.). Contaminating
cells were mainly CD45− cells in both dM and dNK cell samples.
DM and dNK cells were cultured in Ham F12: DMEM gluta-
max (V:V) medium (Gibco) supplemented with 15% of fetal calf
serum (PAA), penicillin (0.1U/l) and streptomycin (1.10−8 g/l)
(Gibco).
REAL-TIME RT-PCR OF TLR mRNAs IN dMs AND dNK CELLS
Total RNA was extracted from purified dM and dNK cells and
from decidual mononuclear cells by using the RNeasy Mini
kit (Qiagen) and on-column DNase digestion using the RNase-
free DNase set (Qiagen). Total RNA (10 ng) was reverse tran-
scribed with the High Capacity cDNA Reverse Transcription kit
(Applied Biosystems), and genes of interest were pre-amplified
with the Taqman PreAmp Master Mix as recommended by
the manufacturer (Applied Biosystems). The resulting cDNA
was used as a template for Taqman real-time PCR on an
ABI 7700 Prism instrument (Applied Biosystems). Relative gene
expression levels were determined with primer/probe sets from
Applied Biosystems (Table 1). CDKN1B served as an endoge-
nous control to normalize loaded cDNA samples. Relative gene
expression between dM or dNK samples and a reference decid-
ual mononuclear cell sample was determined by the 2−ct
method.
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FLOW CYTOMETRY ANALYSIS OF TLR2, TLR3, AND TLR4 EXPRESSION
IN dM AND dNK CELLS
Immediately after isolation, decidual mononuclear cells were
incubated with FcR blocking reagent (Miltenyi) and stained
with Amcyan-labeled anti-CD45, Pacific Blue-labeled anti-
CD14, Alexa700-labeled anti-CD56 (Becton Dickinson),
PE-TexasRed-labeled anti-CD3 (Beckman Coulter) and APC-
labeled anti-TLR2 or PE-labeled anti-TLR3 or APC-labeled
anti-TLR4 (eBioscience) antibodies. For TLR3 staining, cells
were permeabilized (Cytofix/Cytoperm kit, BD Biosciences). For
each TLR staining, an isotype matched Ig was used as negative
control. TLR expression on dMs (CD45+ CD14+ CD3− CD56−)
and dNK cells (CD45+ CD14− CD3− CD56bright) were analyzed
by flow cytometry with an LSRII 2-Blue 2-Violet 3-Red 5-Yelgr
laser configuration (BD Biosciences) and FlowJo 9.1.3. software
(Tristar).
dM AND dNK CELL STIMULATION WITH TLR AGONISTS
Stimulation with TLR agonists were performed on dMs (n = 13)
and dNK cell (n = 11) samples purified with magnetic beads.
Purified dMs were seeded at 2 × 106 cells/ml and stimulated or
not for 24, 48 or 72 h with TLR agonists (Table 2) (Invivogen).
Purified dNK cells were seeded at 2 × 106 cells/ml with 2 ng/ml
IL-15 and were stimulated for 24 or 72 h with TLR agonists, as for
dMs. Supernatants were collected, cleared (5min at 10 000 rpm)
and stored at −80◦C until cytokine quantification.
MULTIPLEX CYTOKINE ANALYSIS
Cytokines were measured by a Luminex assay with the Human
Cytokine 25-plex antibody bead kit as recommended by the
manufacturer (Invitrogen). For each sample, non-stimulated and
stimulated conditions were run on the same Luminex plate.
Table 1 | Applied Biosystems primer/probe sets used for realtime
qPCR of TLR mRNAs.
Primer/probe sets
TLR1 Hs00413978_m1
TLR2 Hs01014511_m1
TLR3 Hs00152933_ml
TLR4 Hs00152939_m1
TLR5 Hs00152825_m1
TLR6 Hs01039989_s1
TLR7 Hs00152971_m1
TLR8 Hs00607866_mH
TLR9 Hs00370913_s1
CDKN1B Hs00153277_m1
Table 2 | TLR agonists used for dM and dNK cell stimulation.
Agonist Concentration
TLR2 HKLM 2.5 × 108 cells/ml
TLR3 Poly(I:C) 50μg/ml
TLR4 LPS E. Coli K12 1μg/ml
TLR7/8 R848 2.5μg/ml
TLR9 Type C CpG oligonucleotide ODN M362 5μM
STATISTICAL ANALYSIS AND GRAPHICS
For each cytokine detected in a stimulated dM or dNK cell
supernatant, we selected the time point corresponding to the
largest fold change. A non-parametric permutation test for
paired samples was used to compare the level of secretion in
non-stimulated vs. stimulated conditions, p < 0.05 being con-
sidered significant. Statistical analyses were performed using
R software (R Foundation for Statistical Computing, Vienna,
Austria; http://www.R-project.org). Polar plots and histograms
were generated with Sigmaplot version 12.5 and GraphPad Prism
version 5.0.
RESULTS
dMs AND dNK CELLS EXPRESS TLR1-9 TRANSCRIPTS
TLR expression by dMs and dNK cells has not previously been
explored. For this purpose, reverse-transcribed RNA from a
decidual mononuclear cell sample and from purified dMs and
dNK cells were submitted to Taqman qPCR for TLR genes
1–9. As previously reported, all TLR mRNAs were detected in
the decidual mononuclear cell sample (Canavan and Simhan,
2007; Krikun et al., 2007). In this sample, TLR4 mRNA was
the strongest expressed transcript, whereas TLR3, TLR6, TLR7,
TLR8, and TLR9 mRNA were less expressed (data not shown).
The relative quantification of dM and dNK cell TLR tran-
scripts was performed using this decidual mononuclear cell
sample as reference. TLR1–9 transcripts were detected in dMs,
with interindividual variability (Figure 1A). In dMs, TLR4,
TLR6, TLR8, and TLR9 mRNA expression was lower than
TLR1, TLR2, TLR5, and TLR7 mRNA expression, and TLR3
mRNA was the most strongly expressed (Figure 1A). All TLR
mRNAs were also detected in dNK cells (Figure 1B) but at
levels lower than in dMs and with interindividual variability.
TLR7 and TLR8 mRNAs were weakly expressed in dNK cells,
while TLR3 mRNAs was the most strongly expressed transcript
(Figure 1B).
TLR2, TLR3, and TLR4 protein expression on dMs and dNK
cells was further investigated by flow cytometry immediately
after their isolation. The TLR expression on dMs and dNK cells
of a representative sample is displayed on Figure 1C left panel.
dMs and dNK cells expressed cell-surface TLR2 and TLR4 pro-
teins, as well as intracellular TLR3. The percent medians of
TLR expression on 16 decidual mononuclear cell samples are
shown on Figure 1C right panel. TLR2, TLR3 and TLR4 pro-
teins were respectively expressed on 93.89 ± 0.93, 86.12 ± 2.96,
and 88.31 ± 1.82 (mean ± s.e.m.) percent of dMs. The per-
cent of TLR2, TLR3, and TLR4 protein expressing dNK cells
was lower than dMs. Indeed, 58.52 ± 4.05, 89.36 ± 1.41 and
71.96 ± 4.31 (mean ± s.e.m.) percent of dNK cells express
TLR2, TLR3, and TLR4 protein. The interindividual variabil-
ity of TLR2, TLR3, and TLR4 protein expression by dMs and
dNK cells was not correlated to the term of pregnancy (data not
shown).
Together, these results show that TLR1-9mRNAs are expressed
in both dMs and dNK cells, and that all TLR transcripts are
expressed more strongly in dMs than in dNK cells. TLR2, TLR3,
and TLR4 protein expression checked by flow cytometry was also
positive on both dMs and dNK cells.
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FIGURE 1 | Expression of TLR mRNAs and of TLR2, TLR3, and TLR4
protein by dM and dNK cells. TLR1, TLR2, TLR3, TLR4, TLR5 TLR6,
TLR7, TLR8, and TLR9 mRNA expression in purified dMs (A) and dNK
cells (B) was quantified by RT-qPCR. Each dot represents one sample,
dMs and dNK cells purified by flow sorting or by magnetic beads are
depicted by black squares and gray circles respectively. Relative TLR
gene expression was determined by the 2−CT method. TLR gene
expression was normalized to the endogenous gene CDKN1B and a
decidual mononuclear cell sample was used as reference. TLR2, TLR3,
and TLR4 protein expression on dMs and dNK cells were investigated by
flow cytometry (C). Immediately after isolation, decidual mononuclear
cells were incubated with FcR blocking reagent and stained with specific
anti-TLR antibodies, dMs (CD45+ CD3− CD56− CD14+) and dNK cells
(CD45+ CD14− CD3− CD56bright) were gated and analyzed for TLR
expression. TLR2, TLR4, and intracellular TLR3 expression on dMs and
dNK cells of a representative sample is displayed (left panel). Percent of
positive dMs and dNK cells for each TLR are represented (right panel),
each dot represents one sample (n = 16).
dMs RESPOND TO TLR2, TLR3, TLR4, TLR7/8 AND TLR9 AGONISTS BY
ENHANCING THEIR SECRETION OF PRO-INFLAMMATORY CYTOKINES
(IL-1β, TNF-α, IL-6, AND IL-8)
To test TLR functionality, culture supernatants from pri-
mary dMs stimulated or not with specific agonists for 24–
72 h were analyzed in a multiplex cytokine assay. Sixteen
cytokines were detected in unstimulated dM supernatants
(data not shown). Among them, 13 showed a statisti-
cally significant fold change in response to at least one
TLR agonist (Figure 2 and Table 3). IL-2RA, IL-15, and
IP-10/CXCL10 did not show any fold change in response to TLR
agonists.
Secretion of the pro-inflammatory cytokines IL-1β, TNF-α,
IL-6, and/or IL-8 was increased in dM supernatants after TLR2,
TLR3, TLR4, TLR7/8, and TLR9 stimulation with specific ago-
nists. Regarding TLRs that sense microbial membrane patterns,
pro-inflammatory cytokine induction was stronger after TLR2
than TLR4 stimulation, except for IL-8 which secretion was
weakly enhanced in both conditions (Figures 2A,C). TLR2 stimu-
lation induced a statistically significant increase in IL-1β, TNF-α,
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FIGURE 2 | Fold increases in cytokine secretion by dMs stimulated
with TLR2, TLR3, TLR4, TLR7/8, and TLR9 agonists. Fold increases
in cytokine levels in supernatants of purified dMs incubated with
TLR2 agonist (HKLM, n = 7) (A); TLR3 agonist (poly(I:C), n = 9) (B);
TLR4 agonist (LPS, n = 7) (C); TLR7/8 agonist (R848, n = 6) (D), or
TLR9 agonist (CpG ODN M362, n = 9) (E) are represented on polar
plot with a common logarithmic scale (circles). Each colored triangle
represents one sample and the red line represents the median. A
non-parametric paired permutation was performed: ∗p < 0.05 and
∗∗p < 0.01.
and IL-6 secretion by dMs (median 2.39, 3.83, and 3.60-fold,
respectively; Figure 2A and Table 3). Induction of these four pro-
inflammatory cytokines by TLR4 stimulation was observed but
showed interindividual variability (Figure 2C). Only a significant
induction of IL-1β and TNF-α secretion was detected after TLR4
stimulation (median 1.5-fold for both cytokines; Figure 2C and
Table 3).
Regarding TLRs that sense pathogenic nucleic acids, dM stim-
ulation with TLR3 agonist induced significant secretion of the
four pro-inflammatory cytokines, with median fold increases of
1.75 for IL-1β, 1.64 for IL-8, 2.55 for TNF-α, and 2.36 for IL-6
(Figure 2B and Table 3). TLR7/8 stimulation strongly and sig-
nificantly enhanced secretion of IL-1β, TNF-α, IL-6, and IL-8
in all the samples, with median fold increases of 3.63, 3.12,
3.91, and 1.64, respectively (Figure 2D and Table 3). Among all
the TLRs, TLR7/8 stimulation of dMs resulted in the strongest
increase in IL-1β and IL-6 secretion (Table 3). The TLR9 ago-
nist enhanced IL-1β, IL-6, and IL-8 but not TNF-α secretion
(median fold changes of 1.29, 2.48, 1.62, and 0.89 respectively)
(Figure 2E). TLR9 stimulation led to a statistically significant
increase in IL-6 and IL-8 secretion in all the samples (Figure 2E
and Table 3).
These results show that TLR2, TLR3, TLR4, TLR7/8, and
TLR9 are functional in dMs, as their activation with specific
agonists induces statistically significant increases in the secretion
of at least one pro-inflammatory cytokine (IL-1β, TNF-α, IL-6,
and/or IL-8).
TLR2, TLR3, TLR4, AND TLR7/8 BUT NOT TLR9 AGONISTS ENHANCE dM
SECRETION OF THE ANTI-INFLAMMATORY CYTOKINES IL-1RA
AND IL-10
Interestingly, dM activation by TLR agonists also enhanced the
secretion of IL-1RA and IL-10, two anti-inflammatory cytokines.
TLR2, TLR3, TLR4, and TLR7/8 activation led to a significant
increase in IL-1RA secretion, with median fold increases of 1.15–
1.80 after TLR2, TLR3, and TLR7/8 stimulation (Figures 2A–D).
IL-1RA secretion was inhibited by TLR9 activation in 6 out of
8 test samples, with a median change of 0.89-fold (Figure 2E
and Table 3). As IL-1RA antagonizes the pro-inflammatory
cytokine IL-1β, and as the secretion of these two factors was
generally enhanced 72 h post-stimulation, we compared their
basal and stimulated secretion at this time point. Unstimulated
dMs secreted significantly (10-fold) more IL-1RA than IL-1β
(Figure 3). After TLR2, TLR3, TLR4 and TLR7/8 activation,
the increase in IL1-β secretion reduced the IL-1RA/IL-1β ratio
by 2.4- to 6.5-fold when compared to unstimulated conditions
(Figure 3). However, the modest increase in IL-1RA secretion
under TLR stimulation was enough to maintain this balance
in favor of IL-1RA, as the median IL-1RA/IL-1β ratio was
always higher than 5:1 (Figure 3). Interestingly, dM stimula-
tion with TLR2, TLR3, TLR4, and TLR7/8 agonists led to a
robust increase in IL-10 secretion (median fold increase 1.64–
5.86) (Figures 2A–D). After TLR9 activation, IL-10 secretion by
dMs declined in all samples (median 0.62-fold) (Figure 2E and
Table 3).
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FIGURE 3 | Ratio of IL-1RA/IL-1β secreted by CD14+ dMs after TLR2,
TLR3, TLR4, TLR7/8, and TLR9 activation. The IL-1RA/IL-1β ratio of
unstimulated and stimulated dMs used for TLR2, TLR3, TLR4, TLR7/8, and
TLR9 stimulation is reported (median and range). The IL-1RA/IL-1β ratio of
all unstimulated (us) dM samples used for the study is also reported to the
left of the graph (median and range). A non-parametric paired permutation
was performed between IL-1RA and IL-1β secretion (ap < 0.05, bp < 0.01,
and cp < 0.001) and between unstimulated and TLR-stimulated dMs
IL-1RA/IL-1β ratio (∗p < 0.05, ∗∗p < 0.01).
Thus, TLR activation of dMs upregulated not only pro-
inflammatory cytokines but also the anti-inflammatory cytokines
IL-10 and IL1-RA. IL-10 was the strongest induced cytokine
following TLR2, TLR4, and TLR7/8 activation. The pro and
anti-inflammatory cytokine profile highlights a tolerogenic char-
acteristic of dMs under TLR activation. One peculiar feature of
dMs was the inhibition of IL-10 and IL-1RA secretion following
TLR9 activation.
TLR2, TLR3, TLR4, TLR7/8, AND TLR9 ACTIVATION OF dMs MODULATES
IL-12, β-CHEMOKINE, MIG, MCP-1, AND GM-CSF SECRETION
Cytokines involved in immune cell crosstalk include IL-
12, β-chemokines, MIG/CXCL9, MCP-1/CCL2, and GM-CSF.
Unstimulated dMs secreted IL-12 (Table 3), and this secretion
was upregulated by TLR2, TLR3, TLR4, and TLR7/8 agonists, by
a median of 1.24- to 1.59-fold (Figures 2A–D and Table 3). IL-12
upregulation was significant for TLR2, TLR4, and TLR7/8 agonist
stimulation (Figures 2A,C,D and Table 3).
The β-chemokines MIP-1α/CCL3, MIP-1β/CCL4, and
RANTES/CCL5 were detected in the supernatants of unstimu-
lated dMs (Table 3). MIP-1α secretion by dMs was upregulated
by all the TLR stimulations, with a median of 1.21- to 2.96-fold
(Figure 2 and Table 3). However, only MIP-1α enhancement
for TLR2 activation was significant, owing to interindividual
variability (Figure 2A). MIP-1β was significantly upregulated
after TLR2, TLR4, TLR3, and TLR7/8 activation (Figures 2A–D;
median fold increase respectively 1.55, 1.75, 1.80, and 1.84).
RANTES secretion by dMs was enhanced by TLR2, TLR3, TLR4,
and TLR7/8 agonists and was significant for TLR2, TLR3, and
TLR4 (Figures 2A–D and Table 3). Interestingly, after TLR9 acti-
vation, RANTES secretion declined with a median of 0.45-fold
(Figure 2E and Table 3).
DM secretion of MIG cytokine was also upregulated by
TLR2, TLR3, TLR4, and TLR7/8 agonists, in a statistically
significant manner for TLR2 and TLR7/8 (median fold increase
1.24 and 3.48, respectively; Figures 2A,D and Table 3). MCP-1
and GM-CSF are involved in monocyte/macrophage recruitment.
MCP-1 secretion by dMs was enhanced after TLR3, TLR7/8,
and TLR9 activation, and significantly for TLR7/8 and TLR9
(Figures 2B,D,E). GM-CSF secretion was enhanced by all the
TLR agonists, significantly by TLR2, TLR3, TLR4, and TLR9
(Figure 2). TLR7/8 activation resulted in the largest increase in
GM-CSF secretion (median fold increase 4.6), but the change did
not reach statistical significance (Figure 2D and Table 3).
Together, these results show that dM secretion of IL-12 and
GM-CSF and of several chemokines (MIP-1α, MIP-1β, RANTES,
MIG, MCP-1) is enhanced by TLR activation.
dNK CELLS RESPOND TO TLR2, TLR3, TLR4, TLR7/8, AND TLR9
AGONISTS BY ENHANCING THEIR SECRETION OF
PRO-INFLAMMATORY CYTOKINES (IFN-γ, IL-6 AND IL-8)
Culture supernatants of primary dNK cells incubated with TLR
agonists for 24–72 h were analyzed as for dMs. Fourteen cytokines
were spontaneously secreted by dNK cells (data not shown).
Among them 11 showed a statistically significant fold change after
TLR stimulation (Figure 4 and Table 4), whereas IL-12, IP-10,
and MIG did not.
Unstimulated dNK cells secreted the pro-inflammatory
cytokines IFN-γ, TNF-α, IL-6, and IL-8, and these four cytokines
were upregulated after TLR2, TLR3, TLR4, TLR7/8, and TLR9
stimulation (Table 4). TNF-α was weakly expressed by dNK cells,
and only by 8 of the 14 samples tested. Thus, although TNF-α
secretion was enhanced by TLR3, TLR4, and TLR9 stimula-
tion, the change was not statistically significant because of the
small number of samples in which it was detected (Figure 4 and
Table 4).
TLR2 stimulation significantly enhanced IFN-γ, IL-6, and IL-
8 secretion by dNK cells (median fold increase 1.54, 2.10, and
1.48, respectively), and all the samples responded (Figure 4A
and Table 4). TNF-α secretion was detected and enhanced in 5
of 8 samples submitted to TLR2 stimulation, and the p-value
was the smallest possible given the sample size available (p =
0.062) (Table 4). IFN-γ, IL-6, and IL-8 secretion by dNK cells was
also significantly enhanced upon TLR4 stimulation, with median
fold increases of respectively 1.61, 2.57, and 1.32 (Figure 4C
and Table 4). Regarding intracellular TLRs, TLR3, and TLR7/8
stimulation significantly upregulated IFN-γ, IL-6, and IL-8 secre-
tion by dNK cells, by more than 3-fold for IFN-γ and IL-6
(Figures 4B,D and Table 4). TLR7/8 stimulation led to a signif-
icant increase in TNF-α secretion (median fold increase 1.32),
TNF-α being detected and upregulated in 6 of the 8 samples
tested (Figure 4D and Table 4). TLR9 stimulation also enhanced
IFN-γ, IL-6, and IL-8 secretion by dNK cells (Figure 4E and
Table 4), but the increase in these pro-inflammatory cytokines
did not reach statistical significance, owing to interindividual
variability.
These results show that TLR2, TLR3, TLR4, and TLR7/8 are
functional in dNK cells, as their stimulation by specific agonists
significantly upregulates the pro-inflammatory cytokines IFN-γ,
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FIGURE 4 | Fold increases in cytokine secretion by dNK cells stimulated
with TLR2, TLR3, TLR4, TLR7/8, and TLR9 agonists. Fold increases in
cytokine levels in the supernatants of purified dNK cells incubated with
TLR2 agonist (HKLM, n = 8) (A); TLR3 agonist (poly(I:C), n = 8) (B); TLR4
agonist (LPS, n = 8) (C); TLR7/8 agonist (R848, n = 8) (D) or TLR9 agonist
(CpG ODN M362, n = 6) (E) are represen ted on polar plot with a common
logarithmic scale (circles). Each colored triangle represents one sample, and
the red line represents the median. A non-parametric paired permutation
was performed: ∗p < 0.05 and ∗∗p < 0.01. #Lowest probability that can be
reached.
IL-6, and IL-8. The response to TLR9 stimulation was highly vari-
able: the pro-inflammatory cytokines were upregulated in some
samples, but none of the median fold increases was statistically
significant.
TLR2, TLR3, TLR4, TLR7/8, AND TLR9 ACTIVATION MODULATES dNK
CELL SECRETION OF ANTI-INFLAMMATORY CYTOKINES,
β-CHEMOKINES, MCP-1 AND GM-CSF
IL-1RA and IL-2RA were the only anti-inflammatory cytokines
secreted by dNK cells. Basal IL-1RA secretion was 3-fold
lower than that observed with dMs (data not shown). IL-1RA
secretion by dNK cells was significantly enhanced by all the
TLR agonists (Figure 4). As CD56bright CD16− NK cells are
reported to constitutively express the high-affinity IL-2 receptor
(IL2RA/IL2RB/IL2RG) (Robertson, 2002), it was not surprising
to observe IL-2RA secretion by unstimulated dNK cells. IL-2RA
secretion was significantly upregulated by TLR2, TLR3, TLR7/8,
and TLR9 stimulation, whereas TLR4 activation did not repro-
ducibly increase IL-2RA secretion (Figure 4C).
The β-chemokines MIP-1α, MIP-1β, and RANTES were
detected in dNK cell supernatants at basal levels respectively
16-fold and 3-fold lower than and identical to those of dMs
(data not shown). DNK cells activated by TLR2, TLR3, TLR4,
and TLR7/8 agonists significantly upregulated their secretion
of the three β-chemokines, by a median of 1.27- to 2.12-fold
for MIP-1α, 1.23- to 1.36-fold for MIP-1β, and 1.21- to 1.41-
fold for RANTES (Figures 4A–D and Table 4). TLR9 activa-
tion significantly enhanced MIP-1α secretion (median 2.46-fold);
MIP-1β secretion was also enhanced but the change did not reach
statistical significance (Figure 4E). Half of the 6 tested dNK cell
samples showed an increase or decrease in RANTES secretion
after TLR9 activation (Figure 4E).
DNK cells secreted both MCP-1 and GM-CSF. The basal level
of MCP-1 secretion was 30-fold lower than that observed with
dMs, while GM-CSF secretion was of the same order with the
two cell types (data not shown). Significant increases in MCP-1
secretion by dNK cells were observed after TLR2, TLR4, TLR7/8,
and TLR9 activation (Figures 4A,C–E). TLR3 activation induced
the largest increase in MCP-1 secretion (median 2.43-fold), but
the change was not statistically significant because secretion was
inhibited in one sample (Figure 4B and Table 4). GM-CSF secre-
tion after TLR2, TLR3, TLR4, TRL7/8, and TLR9 activation was
significantly increased (Figure 4).
Together, these results show that TLR activation enhances dNK
cell secretion of the anti-inflammatory cytokines IL-1RA and IL-
2RA, the chemokines MIP-1α, MIP-1β, RANTES, and MCP-1,
and the cytokine GM-CSF.
COMPARISON OF CYTOKINE PROFILES OF dMs AND dNK CELLS
ACTIVATED BY INTRACELLULAR AND CELL-SURFACE TLRs
Stimulated dMs and dNK cells display distinct cytokine profiles:
IL-10, IL-1β, IL-12, and MIG upregulation being specific of dMs,
whereas only dNK cells enhanced IFN-γ and IL-2RA secretion
(Figure 5).
No major differences were seen between dMs stimulated
by surface TLRs sensing microbial membrane patterns and
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FIGURE 5 | Comparison of the cytokine profiles and median fold
increases of cytokine secretion by dMs and dNK cells
stimulated with TLR agonists. The median fold increases in
cytokine secretion after TLR2, TLR3, TLR4, TLR7/8, and TLR9
stimulations of dMs (A) and dNK cells (B) are summarized on
the same polar plot.
intracellular TLRs sensing microbial nucleic acids (Figure 5A),
although only intracellular TLR3, TLR7/8, and TLR9 activation
significantly enhanced MCP-1 and IL-8 secretion. In addition,
TLR9 activation of dMs resulted in an intriguing cytokine pro-
file (Figure 5A): this was the only condition in which secretion
of the chemokine RANTES and the anti-inflammatory cytokines
IL-1RA and IL-10 was not enhanced or was inhibited.
IL-1RA, MCP-1, and GM-CSF secretion by dNK cells was
enhanced more strongly by intracellular TLRs that sense micro-
bial nucleic acid (TLR3, TLR7/8, and TLR9) than by activation of
cell-surface TLRs that sense microbial membrane patterns (TLR2
and TLR4) (Figure 5B and Table 4). In addition, the strongest
enhancement of IFN-γ secretion by dNK cells was observed after
activation of the intracellular TLR3 and TLR7/8 (Figure 5B and
Table 4).
DISCUSSION
DMs and dNK innate immune cells present in the decidua, have
a crucial role in embryo implantation and fetal development
(Hanna et al., 2006; Lash et al., 2006a,b; Houser et al., 2011). Their
involvement in the initiation of immune responses to pathogens
was strongly suspected but remained to be demonstrated.
We report for the first time that, during the first trimester of
pregnancy, human decidual macrophages and NK cells (i) dif-
ferentially express TLR1-9 mRNAs, (ii) express TLR2, TLR3, and
TLR4 proteins, and (iii) possess functional TLRs that are known
to sense a broad variety of PAMPs, includingmicrobial membrane
and nucleic acid patterns. Specific agonists of TLR2, TLR3, TLR4,
TLR7/8, and TLR9 induced dMs and dNK cells to increase their
secretion of pro-inflammatory and anti-inflammatory cytokines,
as well as cytokines and chemokines involved in immune cell
crosstalk. DMs and dNK cells displayed different cytokine pro-
files: IL-1β, IL-10, and IL-12 secretion was specific to dM cells,
whereas IFN-γ secretion was specific to dNK cells. Most of the
cytokines secreted by both cell types were present at higher
concentrations in dM supernatants.
An appropriate pro-inflammatory/anti-inflammatory
cytokine balance within the decidua basalis is required to support
fetal development, and must therefore be preserved during
antimicrobial responses triggered by TLR activation, in order to
limit inflammation-induced tissue damage and thus to maintain
a successful pregnancy.
Besides their pro-inflammatory actions, IL-6 induces secre-
tion of the angiogenic factor VEGF, while IL-8 is involved in
fetal implantation by stimulating placental trophoblast cell inva-
sion within the decidua (Hanna et al., 2006; Barrientos et al.,
2009). Thus, these cytokine have a crucial builder function dur-
ing pregnancy (Le Bouteiller and Tabiasco, 2006). IL-6 and IL-8
were secreted by both dMs and dNK cells, and their secretion was
enhanced by TLR activation. Thus, dMs and dNK cells probably
maintain their IL-6 and IL-8-related builder function even after
TLR activation.
The changes observed here in the dM cytokine profile after
TLR activation are compatible with the results of previous tran-
scriptome studies suggesting that dMs present features of both
pro-inflammatory and tolerogenic macrophages (Houser et al.,
2011; Svensson et al., 2011). Indeed, dMs increased IL-1β and
TNF-α secretion (pro-inflammatory cytokines), together with
IL-6 and IL-8, in response to TLR activation, while secretion
of the anti-inflammatory cytokines IL-1RA and IL-10 was also
enhanced. IL-1β secretion is tightly regulated and requires the
activation of inflammasome complex containing activated cas-
pase 1 for the cleavage of cytosolic inactive pro-IL-1β protein in
mature IL-1β, which is secreted (Martinon et al., 2002; Dinarello,
2009). Whereas TLRs activation is known to induce pro-IL-1β
protein expression, inflammasome complex activation involves
the recognition of pathogen or damage-cell associated molec-
ular patterns by intracellular inflammasome sensor (Dinarello,
2009). However, constitutively activated inflammasome were
reported in human blood monocytes and dendritic cells (Nguyen
et al., 2007; Netea et al., 2009; Carta et al., 2011; He et al.,
2013; Snodgrass et al., 2013) and suggest that the regulation
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of inflammasome-mediated IL-1β production in APCs is cell-
specific. The secretion of IL-1β by dMs in the absence of exoge-
neous TLR activation suggests that dMs could have an activated
inflammasome in the decidual environment.
Once secreted, IL-1β pro-inflammatory activity is regulated
by its antagonist IL-1RA. IL-1RA competes with IL-1β for its
receptors and has an important role in regulating inflamma-
tion (Arend, 2002). We found that the IL1RA/IL-1β balance in
dM supernatants in both basal and TLR-stimulated conditions
always favored IL-1RA. IL-1RA secretion by dNK cells was also
enhanced by TLR stimulation. IL-1RA secretion by dMs and
dNK cells after TLR activation might help to counterbalance the
pro-inflammatory action of IL-1β and to maintain a fetotolerant
microenvironment. IL-10 plays a crucial role in tissue homeosta-
sis, by preventing bystander tissue damage during inflammatory
processes such as inflammatory bowel disease (Paul et al., 2012).
Interestingly, mice lacking IL-10 expression are more susceptible
to preterm delivery when challenged with TLR4 or TLR9 ligands
(Robertson et al., 2007; Thaxton et al., 2009). In this latter mouse
model, IL-10 was shown to prevent fetal loss by inhibiting pla-
cental invasion by cytotoxic NK cells and macrophages and by
down-regulating pro-inflammatory cytokines, including TNF-α
(Murphy et al., 2009; Thaxton et al., 2009). IL-10 has also been
reported to modulate the responses of primary human placental
cells to TLR2 and TLR4 ligands, reducing their secretion of IL-1β,
IL-6, and IL-8 (Bayraktar et al., 2009). Since dMs spontaneously
secrete IL-10 and TLR2, TLR3, TLR4, and TLR7/8 activation
induces a strong secretion of IL-10, a cross-talk between dMs
and trophoblast placental cells might occur. The peculiar cytokine
profile of dMs observed under TLR activation with the secretion
of both IL-1β, TNF-α, IL-6 pro-inflammatory and IL-10, IL-1RA
anti-inflammatory cytokines as well as a low IL-12 secretion,
is closely related to the cytokine profile of the immunoregula-
tory Macrophage M2b subset (Mantovani et al., 2004). Enhanced
IL-10 secretion by dMs after TLR activation might help main-
tain fetal tolerance by damping the action of pro-inflammatory
cytokines, thus underlining the tolerogenic function of dMs.
Our results reveal that TLR4 activation induced the lowest
cytokine secretion by dMs. TLR4 activation of monocyte derived
macrophages (MDM) in the same experimental conditions gave
very high fold increase of TNF-α, IL-6, IL-12, IL-10, and β-
chemokines (data not shown). Peripheral blood monocytes were
shown to display a lower TLR4-induced cytokine secretion when
they were pre-exposed to trophoblast placental cells (Fest et al.,
2007). This education ofmonocytes by trophoblasts could explain
why TLR4-induced cytokine secretion of ex vivo primary dMs
which are in close contact with placental cells is low.
Interestingly, the dM cytokine profile observed after TLR9
activation was distinct from that induced by the other TLR ago-
nists. Indeed, IL-1RA and IL-10 secretion by TLR9-activated dMs
was not enhanced and was even sometimes reduced. Several
observations suggest that pre-eclampsia (PE), a shallow implan-
tation syndrome, could results from a pro/anti-inflammatory
cytokine imbalance due to inappropriate TLR activation (Sado
et al., 2011; Chatterjee et al., 2012). Emerging evidence sug-
gests that TLR9 stimulation by mitochondrial DNA released from
necrotic trophoblasts could induce local and systemic inflam-
matory responses and thereby contribute to the development
of PE (Goulopoulou et al., 2012; Scharfe-Nugent et al., 2012).
Moreover, a decrease in IL-10-expressing dMs has been observed
in the decidua of PE patients (Schonkeren et al., 2011). Our
finding that TLR9 activation enhances dMs secretion of pro-
inflammatory cytokines but not that of the anti-inflammatory
cytokines IL-10 and IL-1RA suggests a disruption of the
pro/anti-inflammatory cytokine balance essential to maintain
local materno-fetal tolerance.
Like their peripheral blood (pNK) and non-pregnancy uter-
ine (uNK) counterparts, dNK cells exhibited enhanced IFN-γ
secretion after TLR activation (Sivori et al., 2004; Eriksson et al.,
2006; Kim et al., 2012; Souza-Fonseca-Guimaraes et al., 2012).
Direct sensing by pNK cells of TLR3 and TLR9 agonists, as well
as human cytomegalovirus (HCMV) and Mycobacterium bovis
through TLR2, is reported to induce their IFN-γ-producer effec-
tor function and to increase their cytolytic activity (Sivori et al.,
2004; Marcenaro et al., 2008; Muntasell et al., 2013). Interestingly,
a recent study shows that dNK cells, which produce cytokines and
chemokines during normal pregnancy, develop cytotoxic activity
against HCMV-infected autologous decidual fibroblasts (Siewiera
et al., 2013). Our results show that activation of dNK cells through
their TLRs can activate their IFN-γ-secreting effector function.
Whether or not TLR activation also shapes the cytotoxic effec-
tor function of dNK cells remains to be determined. DMs are not
detected in purified dNK cell samples, however it cannot be totally
excluded that remaining stromal decidual cells could indirectly
support dNK cell IFN-γ production (Schaefer et al., 2005; Patel
et al., 2012).
TLR activation of dMs and dNK cells enhances the secre-
tion of several cytokines and chemokines involved in immune
cell crosstalk. Among them, GM-CSF has a key role in embryo
implantation and development, as it acts as a growth factor for
trophoblastic cells (Robertson, 2007). Indeed, GM-CSF injec-
tion is reported to prevent fetal loss in an abortion-prone mouse
model (Chaouat et al., 1990). Moreover, GM-CSF secretion by
activated dNK cells was recently shown to enhance primary tro-
phoblast migration, thus favoring placentation (Xiong et al.,
2013). Beside its role in placentation, GM-CSF is involved in
monocyte/macrophage recruitment, while MCP-1 also recruits
NK cells (Hamilton, 2002; Robertson, 2002; Deshmane et al.,
2009). The β-chemokines MIP-1α, MIP-1β, and RANTES recruit
CCR5-expressing cells (monocytes, NK, and T cells); monocyte
and CD56bright pNK cell recruitment through MIP-1α secretion
by placental cells has also been reported (Drake et al., 2001).
MCP-1 and β-chemokines are reported to enhance pNK cytolytic
activity (Taub et al., 1995; Robertson, 2002). Here we show that
secretion of these chemokines by both dMs and dNK cells is
enhanced by TLR activation. Together, these chemokines might
enable the recruitment of a large panel of immune cells able
to mount an appropriate response against invading pathogens,
while GM-CSF promotes trophoblast invasion and maintains
placentation.
The TLR-induced cytokine profile of dMs and dNK cells could
influence the T CD4+ cell responses. The TLR activation of dNK
cells results in the enhancement of IFN-γ, which was shown to
prevent Th2 CD4+ T cells proliferation and cytokine synthesis
(Oriss et al., 1997). dMs secrete IL-10 cytokine known to inhibit
proliferation and cytokine response of both Th1 and Th2 CD4+
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T cells (de Waal Malefyt et al., 1991; Fiorentino et al., 1991;
Ding and Shevach, 1992; Del Prete et al., 1993; Joss et al., 2000).
Thus, TLR-induced IL-10 secretion by dMs may prevent the over
proliferation and over activation of CD4+ T cells.
Successful pregnancy was associated with a shift toward a Th2
cytokine biais, whereas a shift toward Th1 cytokine was associ-
ated with recurrent spontaneous abortions (Raghupathy, 2001).
Nevertheless, a moderate Th1 inflammatory environment con-
trolled by decidual regulatory T cells (Treg) is required during
early pregnancy (Mjosberg et al., 2010) and a decrease of decid-
ual Treg cells was associated with miscarriage (Sasaki et al., 2004;
Inada et al., 2013). A cross-talk between dMs and dNK cells was
shown to be involved in Treg induction through the secretion of
IFN-γ by dNK cells, which allows IDO secretion by dMs, which
in turn induces Treg (Vacca et al., 2010). Moreover, decidual Treg
were shown to inhibits autologous T cells proliferation and to
reduce both fetus-specific and non-specific immune responses
(Tilburgs et al., 2008). Under TLR activation, the enhancement
of IFN-γ secretion by dNK cells is thus compatible with fetal
tolerance together with the defense against pathogens.
Interestingly, dMs secrete IL-15 as well as IL-12, secretion
of which is increased after TLR activation. NK cell priming by
IL-15 is known to be required for downstream NK cell activa-
tion (Lucas et al., 2007) and IL-15 is a growth/activation factor
for dNK cells (Verma et al., 2000). As IL-15 is expressed within
the decidua (Marlin et al., 2011), dNK cells are physiologically
primed. Our results suggest that dMs may be involved in this
mechanism. IL-12 is reported to potentiate IFN-γ production
by pNK cells (Fehniger et al., 1999). IFN-γ release by TLR7/8-
activated pNK cells, and by Trypanozoma cruzi-activated cord
blood NK cells through TLR2/4, is dependent on IL-12 produc-
tion by accessory cells (Hart et al., 2005; Guilmot et al., 2013).
Moreover, pNK cell cytotoxic activity induced through TLR7/8
or TLR3 activation is enhanced by an IL-12-related mechanism
(Hart et al., 2005). Thus, IL-15 secretion by dMs and the increase
in IL-12 production after TLR activation could respectively prime
dNK cells and enhance their IFN-γ secretion in the presence of a
pathogen.
In conclusion, we report here for the first time that decid-
ual macrophages and natural killer cells express functional TLR2,
TLR3, TLR4, TLR7/8, and TLR9, and are thus able to sense a
large panel of PAMPs. The cytokine profiles induced by TLR
activation are compatible with simultaneous initiation of antimi-
crobial responses, control of the inflammatory response, and
maintenance of the fetotolerant immune environment.
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